Business / Finance

RSS

Agendia partners with Cryogene and Mist to distribute breast cancer recurrence assay in the Middle East

Agendia, Inc., a world leader in personalized medicine and molecular cancer diagnostics, announced today a partnership agreement to distribute the company’s breast cancer recurrence assay, MammaPrint, in the Middle East.

10 Nov 2016

Alesi Surgical announces entry into lucrative trocar market

Alesi Surgical Limited, the advanced minimally invasive surgery medical device manufacturer, has announced its entry into the lucrative trocar market estimated to be worth $800 million per year, globally.

27 Oct 2016

Braintrain 20:20 receives significant seed investment for new sleep aid device

An award-winning consumer personalised health device manufacturer specialising in sleep aid technologies is gearing up for growth following significant seed investment.

27 Oct 2016

Domain Therapeutics and Medicxi partner to launch Mavalon Therapeutics

Domain Therapeutics, a biopharmaceutical company that specializes in the discovery and development of G protein-coupled receptor (GPCR) drugs, today announces the creation of Mavalon Therapeutics, a company focused on stopping the progression of Parkinson’s disease.

19 Oct 2016

Fortimedix Surgical completes €11M funding round to support launch of world’s first single-port surgery solution

Fortimedix Surgical today announced the completion of an €11M Series A funding round.

14 Oct 2016

Pittcon conference registration opens for 2017

The Registration Committee today announced that conferee registration is now open for Pittcon 2017, the world’s premier annual conference and exposition for laboratory science. The event will be held March 5-9, 2017, at the West Hall of McCormick Place, Chicago, IL.

From Pittcon 4 Oct 2016

Alpine HC announces consolidation of Reposa and Opera brands

Alpine HC, a provider of equipment to care environments, has recently announced some upcoming changes to their Reposa pressure care brand under which they manufacture pressure relieving mattresses, cushions and accessories.

From Opera Care 4 Oct 2016

Professor David Goldstein appointed as chief adviser for AstraZeneca’s genomics initiative

AstraZeneca today announced that Professor David Goldstein will join the Company in the consultative role of Chief Adviser, Genomics to lead its integrated genomics initiative, which was announced in April.

30 Sep 2016

Genix Healthcare celebrates 10th anniversary of first dental practice

Genix Healthcare Ltd celebrated the 10th anniversary of its first dental practice with a special visit by Alec Shelbrooke, the Conservative MP for Elmet and Rothwell.

29 Sep 2016

Promedica partners with Kaonsoft to accelerate development of new mobile healthcare apps

ProMedica, one of Ohio's largest healthcare systems, is partnering with Kaonsoft, an enterprise mobility software company, to form Kapios Health, a healthcare technology company that will focus on the development of medical applications created by ProMedica Innovations inventors.

29 Sep 2016

Wolters Kluwer announces strategic alliance with NSNA to improve student preparation for NCLEX

Wolters Kluwer, a leading global provider of information and point of care solutions for the healthcare industry, today announced a strategic alliance with the National Student Nurses' Association, Inc. that will leverage its trusted NCLEX® content, including Lippincott NCLEX-RN PassPoint, to help nursing students better prepare for the exam.

21 Sep 2016

AXT to exclusively distribute Unchained Labs biologics research tools in Australia, New Zealand

AXT is excited to announce that they have partnered with Unchained Labs and will now be exclusively distributing their innovative and novel range of instruments for the analysis and formulation of biologics in Australia and New Zealand.

From AXT Pty Ltd 20 Sep 2016

Separation Technology shifts manufacturing and operations facility from Sanford to Boerne, Texas

EKF Diagnostics, the global in-vitro diagnostics company, announces that Separation Technology, Inc.

From EKF Diagnostics 9 Sep 2016

Oncovision’s preclinical PET imaging business acquired in agreement with Bruker

PET and SPECT are key molecular imaging technologies for Bruker’s Preclinical Imaging division, allowing Bruker to offer the highest-performance SiPM-PET/SPECT/CT and integrated SiPM-PET/MR imaging systems.

From Bruker BioSpin - NMR, EPR and Imaging 9 Sep 2016

BMG LABTECH doubles manufacturing area to meet global demand for microplate reader products

BMG LABTECH, a world leader in microplate readers, has recorded a rapid increase in revenue over the past years. A new company building provides the additional capacity required for the company's anticipated business growth over the longer term.

From BMG LABTECH GmbH 8 Sep 2016

ITL Virginia to support North American roll-out of Endomag’s Sentimag system

ITL Virginia Inc, the US subsidiary of medical design and manufacturing company ITL, will be supporting the North American roll-out of the Sentimag system following Endomag’s signing of a major distribution deal.

2 Sep 2016

Can-Fite BioPharma reports financial results, provides update on drug development programs

Can-Fite BioPharma Ltd., a biotechnology company with a pipeline of proprietary small molecule drugs being developed to treat inflammatory diseases, cancer and sexual dysfunction, today reported financial results for the six months ended June 30, 2016 and updates on its drug development programs.

27 Aug 2016

Oventus reports early revenues, establishes platform for accelerated growth

Medical device sleep apnoea and snoring disorder company Oventus Medical Ltd. releases its first 4E. The company has established a platform for accelerated growth following a successful IPO raising $12 million and is reporting encouraging early revenue.

26 Aug 2016

mOm raises £630,000 in seed funding to develop revolutionary infant incubator

mOm has raised £630,000 in seed funding from a prominent set of investors to further develop its revolutionary baby incubator. Led by MaSa Partners (a US-based impact fund), investors include Holly Branson (as part of the Virgin Group), Lord Rumi Verjee (as part of the The Rumi Foundation), Continuity Capital, Dr. Joshua Boger, Johannes Heine, Rockspring, and The London Co Investment Fund.

24 Aug 2016

Chris Molloy appointed new CEO of Medicines Discovery Catapult

The Medicines Discovery Catapult has appointed its first Chief Executive Officer. Chris Molloy, who has more than 25 years’ experience in the international life science industry, will lead the MDC in developing new approaches for the discovery and early development of new medicines.